Zobrazeno 1 - 10
of 21
pro vyhledávání: '"William D van Dongen"'
Publikováno v:
Bioanalysis. 12:1231-1241
Background: Hemolysis can result in analyte suppression or enhancement and it can affect the extraction efficiency and analyte stability. Triskelion developed an LC–MS method to monitor hemolysis. The concept can be integrated into existing and new
Autor:
William D van Dongen, Vidya Annavarapu, J. Michael Sutton, Guilherme J Guimaraes, Michael G. Bartlett
Publikováno v:
Journal of the American Society for Mass Spectrometry. 31:1775-1782
As interests increase in oligonucleotide therapeutics, there has been a greater need for analytical techniques to properly analyze and quantitate these biomolecules. This article looks into some of the existing chromatographic approaches for oligonuc
Publikováno v:
Journal of the American Society for Mass Spectrometry. 28:190-199
Hexafluoroisopropanol (HFIP) has been widely used as an acidic modifier for mobile phases for liquid chromatography-mass spectrometry (LC-MS) analysis of oligonucleotides ever since the first report of its use for this purpose. This is not surprising
Autor:
Frédérique L. van Holthoon, Jan H. Toersche, Martha Ingola, William D van Dongen, Anne J. Kleinnijenhuis
Publikováno v:
Bioanalysis. 8:891-904
Background: TNO Triskelion has applied its general workflow for the development of quantitative LC–MS methods for proteins in biological matrices to the quantification of infliximab in rat serum using bottom up μLC–MS/MS. Results/methodology: Th
Publikováno v:
Bioanalysis. 7:1943-1958
Bioanalytical LC–MS for protein quantification is traditionally based on enzymatic digestion of the target protein followed by absolute quantification of a specific signature peptide relative to a stable-isotope labeled analog. The enzymatic digest
Autor:
William D van Dongen, Melody Sauerborn
Publikováno v:
BioDrugs. 28:383-391
Currently, the most bioanalytically challenging drugs are antibody-drug conjugates (ADCs), constructs comprising a monoclonal antibody and a cytotoxic drug connected by a linker. The bioanalytical challenges arise from the heterogeneous nature of ADC
Autor:
Luuk C Renfurm, William D van Dongen
Publikováno v:
Bioanalysis. 6:1159-1165
The 6th European Bioanalysis Forum Open Meeting 20–22 November 2013, Hesperia Tower Hotel, Barcelona, Spain At the 6th European Bioanalysis Forum Open Meeting, held from 20–22 November 2013 in Hesperia Tower Hotel, Barcelona, Spain, bioanalytical
Publikováno v:
van Dongen, W D & Niessen, W M A 2011, ' Bioanalytical LC-MS of therapeutic oligonucleotides ', Bioanalysis, vol. 3, pp. 541-564 . https://doi.org/10.4155/bio.11.8
Bioanalysis, 3, 541-564. Future Science
Bioanalysis, 3, 541-564. Future Science
Therapeutic oligonucleotides (OGNTs) are important biopharmaceutical drugs for the future, due to their ability to selectively reduce or knockout the expression of target genes. For the development of OGNTs, reliable and relatively high-throughput bi
Publikováno v:
Journal of Chromatography B. 788:251-259
A generic method was developed for the fast determination of a wide range of drugs in serum or plasma. The methodology comprises generic solid-phase extraction, on-line coupled to gradient HPLC with tandem mass spectrometric detection (SPE-LC-MS/MS).
Autor:
Jan H.G Jonkman, Ruud J.J.M Steenvoorden, William D van Dongen, Fija M. Lagerwerf, Maarten Honing
Publikováno v:
TrAC Trends in Analytical Chemistry. 19:418-427
In this article, the boundaries of quantitative high-performance liquid chromatography coupled with tandem mass spectrometry (LC–MS–MS) as a bioanalytical tool for clinical pharmacology studies are described. Although LC–MS–MS is a universal,